Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 181

1.

Central venous catheter tip position on chest radiographs: a reply.

Hade AD, Beckmann L, Basappa B.

Anaesthesia. 2020 Jan;75(1):126. doi: 10.1111/anae.14879. No abstract available.

2.

A Canadian consensus forum on the management of patients with advanced prostate cancer.

Saad F, Canil C, Finelli A, Hotte SJ, Malone S, Shayegan B, So AI, Aaron L, Basappa NS, Conter HJ, Danielson B, Gotto G, Hamilton RJ, Izard JP, Kapoor A, Kolinsky M, Lalani AA, Lattouf JB, Morash C, Morgan SC, Niazi T, Noonan KL, Ong M, Rendon RA, Sehdev S, Hew H, Park-Wyllie L, Chi KN.

Can Urol Assoc J. 2019 Nov 5. doi: 10.5489/cuaj.6082. [Epub ahead of print] Review.

PMID:
31702544
3.

A novel small-molecule inhibitor of trefoil factor 3 (TFF3) potentiates MEK1/2 inhibition in lung adenocarcinoma.

Zhang M, Wang B, Chong QY, Pandey V, Guo Z, Chen RM, Wang L, Wang Y, Ma L, Kumar AP, Zhu T, Wu ZS, Yin Z, Basappa, Goh BC, Lobie PE.

Oncogenesis. 2019 Nov 4;8(11):65. doi: 10.1038/s41389-019-0173-8.

4.

Inhibition of TFF3 Enhances Sensitivity-and Overcomes Acquired Resistance-to Doxorubicin in Estrogen Receptor-Positive Mammary Carcinoma.

Poh HM, Chiou YS, Chong QY, Chen RM, Rangappa KS, Ma L, Zhu T, Kumar AP, Pandey V; Basappa, Lee SC, Lobie PE.

Cancers (Basel). 2019 Oct 10;11(10). pii: E1528. doi: 10.3390/cancers11101528.

5.

Management of Advanced Kidney Cancer: Kidney Cancer Research Network of Canada (KCRNC) consensus update 2019.

Hotte SJ, Kapoor A, Basappa NS, Bjarnason G, Canil C, Conter HJ, Czaykowski P, Graham J, Gray S, Heng DYC, Karakiewicz PI, Kollmannsberger C, Lalani AA, North SA, Patenaude F, Soulières D, Violette P, Winquist E, Wood LA, Dudani S, Maloni R, Reaume MN; Kidney Cancer Research Network of Canada.

Can Urol Assoc J. 2019 Oct;13(10):343-354. doi: 10.5489/cuaj.6256. No abstract available.

6.

Brusatol, a Nrf2 Inhibitor Targets STAT3 Signaling Cascade in Head and Neck Squamous Cell Carcinoma.

Lee JH, Rangappa S, Mohan CD; Basappa, Sethi G, Lin ZX, Rangappa KS, Ahn KS.

Biomolecules. 2019 Sep 30;9(10). pii: E550. doi: 10.3390/biom9100550.

7.

Repair of Sinus Venosus Defects With Partial Anomalous Pulmonary Venous Connection in Children by Modified Right Vertical Infra Axillary Thoracotomy.

Rao RK, Varadaraju R, Basappa G, Nagaraja PS.

Innovations (Phila). 2019 Sep 11:1556984519874800. doi: 10.1177/1556984519874800. [Epub ahead of print]

PMID:
31506015
8.

A modified flavonoid accelerates oligodendrocyte maturation and functional remyelination.

Su W, Matsumoto S, Banine F, Srivastava T, Dean J, Foster S, Pham P, Hammond B, Peters A, Girish KS, Rangappa KS, Basappa, Jose J, Hennebold JD, Murphy MJ, Bennett-Toomey J, Back SA, Sherman LS.

Glia. 2020 Feb;68(2):263-279. doi: 10.1002/glia.23715. Epub 2019 Sep 6.

PMID:
31490574
9.

Application of Hereditary Renal Cell Carcinoma Risk Criteria to a Large Prospective Database.

Kushnir I, Kirk L, Mallick R, Kim RH, Graham GE, Breau RH, Lattouf JB, Violette PD, Pautler SE, Care M, Kapoor A, Jewett MAS, Wood L, Tanguay S, Heng DYC, Basappa NS, So A, Pouliot F, Reaume NM.

Clin Oncol (R Coll Radiol). 2019 Aug 1. pii: S0936-6555(19)30290-0. doi: 10.1016/j.clon.2019.07.010. [Epub ahead of print]

PMID:
31378448
10.

Rapid atrophy of cardiac left ventricular mass in patients with non-small cell carcinoma of the lung.

Kazemi-Bajestani SMR, Becher H, Butts C, Basappa NS, Smylie M, Joy AA, Sangha R, Gallivan A, Kavsak P, Chu Q, Baracos VE.

J Cachexia Sarcopenia Muscle. 2019 Oct;10(5):1070-1082. doi: 10.1002/jcsm.12451. Epub 2019 Jul 10.

11.

Triazole-Pyridine Dicarbonitrile Targets Phosphodiesterase 4 to Induce Cytotoxicity in Lung Carcinoma Cells.

Keerthy HK, Mohan S, Basappa, Bharathkumar H, Rangappa S, Svensson F, Bender A, Mohan CD, Rangappa KS, Bhatnagar R.

Chem Biodivers. 2019 Sep;16(9):e1900234. doi: 10.1002/cbdv.201900234. Epub 2019 Aug 29.

PMID:
31287204
12.

Renal cell carcinoma in the Canadian Indigenous population.

Wong ECL, Breau RH, Mallick R, Wood L, Pouliot F, Basappa NS, Tanguay S, Soulières D, So A, Heng D, Lavallée LT, Drachenberg D, Kapoor A.

Curr Oncol. 2019 Jun;26(3):e367-e371. doi: 10.3747/co.26.4707. Epub 2019 Jun 1.

13.

Diabetes and kidney cancer survival in patients undergoing nephrectomy: A Canadian multi-center, propensity score analysis.

Nayan M, Jalali S, Kapoor A, Finelli A, So A, Rendon R, Breau RH, Lavallee LT, Tanguay S, Heng D, Kawakami J, Basappa NS, Bjarnason G, Pouliot F, Hamilton RJ.

Urol Oncol. 2019 Sep;37(9):576.e11-576.e16. doi: 10.1016/j.urolonc.2019.06.006. Epub 2019 Jul 5.

PMID:
31285115
14.

Selumetinib in patients receiving standard pemetrexed and platinum-based chemotherapy for advanced or metastatic KRAS wildtype or unknown non-squamous non-small cell lung cancer: A randomized, multicenter, phase II study. Canadian Cancer Trials Group (CCTG) IND.219.

Melosky B, Bradbury P, Tu D, Florescu M, Reiman A, Nicholas G, Basappa N, Rothenstein J, Goffin JR, Laurie SA, Wheatley-Price P, Leighl N, Goss G, Reaume MN, Butts C, Murray N, Card C, Ko J, Blais N, Gray S, Lui H, Brown-Walker P, Kaurah P, Prentice LM, Seymour L.

Lung Cancer. 2019 Jul;133:48-55. doi: 10.1016/j.lungcan.2019.04.027. Epub 2019 May 1.

PMID:
31200828
15.

Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of cytoreductive nephrectomy for patients with metastatic renal cell carcinoma.

Mason RJ, Wood L, Kapoor A, Basappa N, Bjarnason G, Boorjian SA, Breau RH, Cagiannos I, Jewett MAS, Karakiewicz PI, Kassouf W, Kollmannsberger C, Lalani AA, Lattouf JB, Lavallée LT, Pautler S, Power N, Richard P, So A, Tanguay S, Rendon RA.

Can Urol Assoc J. 2019 Jun;13(6):166-174. doi: 10.5489/cuaj.5786. No abstract available.

16.

Targeting Heparanase in Cancer: Inhibition by Synthetic, Chemically Modified, and Natural Compounds.

Mohan CD, Hari S, Preetham HD, Rangappa S, Barash U, Ilan N, Nayak SC, Gupta VK, Basappa, Vlodavsky I, Rangappa KS.

iScience. 2019 May 31;15:360-390. doi: 10.1016/j.isci.2019.04.034. Epub 2019 May 3. Review.

17.

A checklist to improve the quality of central venous catheter tip positioning.

Hade AD, Beckmann LA, Basappa BK.

Anaesthesia. 2019 Jul;74(7):896-903. doi: 10.1111/anae.14679. Epub 2019 May 6.

PMID:
31062348
18.

Canadian Urological Association/Genitourinary Medical Oncologists of Canada consensus statement: Management of unresectable locally advanced and metastatic urothelial carcinoma.

Warren M, Kolinsky M, Canil CM, Czaykowski P, Sridhar SS, Black PC, Booth CM, Kassouf W, Eapen L, Mukherjee SD, Blais N, Eigl BJ, Winquist E, Basappa NS, North SA; GUMOC.

Can Urol Assoc J. 2019 Apr 26:318-327. doi: 10.5489/cuaj.6015. [Epub ahead of print] No abstract available.

19.

A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration-resistant Prostate Cancer: Canadian Cancer Trials Group Study IND205.

Hotte SJ, Chi KN, Joshua AM, Tu D, Macfarlane RJ, Gregg RW, Ruether JD, Basappa NS, Finch D, Salim M, Winquist EW, Torri V, North S, Kollmannsberger C, Ellard SL, Eigl BJ, Tinker A, Allan AL, Beja K, Annala M, Powers J, Wyatt AW, Seymour L; Canadian Cancer Trials Group (formerly NCIC Clinical Trials Group).

Clin Genitourin Cancer. 2019 Jun;17(3):201-208.e1. doi: 10.1016/j.clgc.2019.03.005. Epub 2019 Mar 15.

PMID:
31056399
20.

Management algorithms for metastatic prostate cancer.

Malone S, Shayegan B, Basappa NS, Chi K, Conter HJ, Hamilton RJ, Hotte SJ, Saad F, So A, Park-Wyllie L, Hew H, McLeod D, Gotto G.

Can Urol Assoc J. 2019 Apr 26. doi: 10.5489/cuaj.5840. [Epub ahead of print] Review.

PMID:
31039111

Supplemental Content

Loading ...
Support Center